Michela Luciano, PhD,  Science Writer—

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in acute myeloid leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as Scientific Writer in 2022. Outside of work she enjoys street photogtaphy, mountain hikes, running, and spending as much time as possible outdoors.

Articles by Michela Luciano, PhD

Music therapy for MS may help with motivation, heat sensitivity

A six-week music therapy intervention significantly reduced psychosocial fatigue — or fatigue that interferes with a person’s motivation and ability to engage in social and daily activities — and heat sensitivity in people with multiple sclerosis (MS), according to data from a clinical trial. Participants who received music therapy…

Quantum seeks faster UK access for MS therapy Lucid-MS

Quantum Biopharma filed a U.K. innovation passport application to streamline the development and review of Lucid-21-302 (Lucid-MS), a therapy designed to promote myelin repair in people with multiple sclerosis (MS). The submission, made via Quantum’s Australian subsidiary, Huge Biopharma Australia, marks the first step to entering the U.K.’s Innovative…

Online training offers real-world, cognitive benefits for MS patients

An online training program for managing memory and cognitive difficulties may help people with multiple sclerosis (MS), a study suggests. The program, delivered entirely through virtual sessions, taught participants practical strategies to boost memory then guided them about using the techniques in real-world situations, such as organizing errands, planning…